Imbio Inc

Imbio Inc. develops AI medical imaging solutions for chronic lung and cardiothoracic diseases. The company provides automated analysis and reporting for COPD, ILD, pulmonary hypertension, and coronary artery calcification, supporting clinical care, trials, and research. Imbio serves physicians, health systems, and patients in APAC, Europe, and the US.